Lipoprotein (a) levels and long-term cardiovascular risk in the contemporary era of statin therapy
SJ Nicholls, WHW Tang, H Scoffone, DM Brennan… - Journal of lipid …, 2010 - ASBMB
Lipoprotein (a)[Lp (a)] has enhanced atherothrombotic properties. The ability of Lp (a) levels
to predict adverse cardiovascular outcomes in patients undergoing coronary angiography
has not been examined. The relationship between serum Lp (a) levels and both the extent of
angiographic disease and 3-year incidence of major adverse cardiovascular events (MACE:
death, myocardial infarction, stroke, and coronary revascularization) was investigated in
2,769 patients who underwent coronary angiography [median Lp (a) 16.4 mg/dl, elevated …
to predict adverse cardiovascular outcomes in patients undergoing coronary angiography
has not been examined. The relationship between serum Lp (a) levels and both the extent of
angiographic disease and 3-year incidence of major adverse cardiovascular events (MACE:
death, myocardial infarction, stroke, and coronary revascularization) was investigated in
2,769 patients who underwent coronary angiography [median Lp (a) 16.4 mg/dl, elevated …
